v3.26.3
Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2026
Jun. 30, 2025
Current assets:    
Cash and cash equivalents $ 67,711 $ 15,039
Prepaid expenses and other assets 537 791
R&D tax incentive receivable 4,579 4,132
Total current assets 72,827 19,962
Property, plant and equipment, net 4 227
Investment in joint venture 51 0
Operating lease right-of-use assets, net 97 258
Total assets 72,979 20,447
Current liabilities:    
Trade and other payables 1,158 6,104
Accrued expenses and other current liabilities 272 696
Operating lease liabilities, current 62 184
Total current liabilities 1,492 6,984
Operating lease liabilities, non-current 34 74
Warrant liabilities 4,080 0
Total liabilities 5,606 7,058
Commitments and contingencies (Note 8)
Stockholders’ equity:    
Common stock, $0.0001 par value – 800,000,000 shares authorized; 12,544,298 and 6,479,333 shares issued and outstanding at June 30, 2026 and 2025, respectively 38 20
Additional paid-in capital 247,769 174,049
Accumulated deficit (176,858) (157,556)
Foreign currency translation reserve (3,576) (3,124)
Total stockholders’ equity 67,373 13,389
Total liabilities and stockholders’ equity $ 72,979 $ 20,447